ANI Pharmaceuticals
ANIP
ANIP
134 hedge funds and large institutions have $241M invested in ANI Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 42 increasing their positions, 44 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
less call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
26% less capital invested
Capital invested by funds: $325M → $241M (-$83.7M)
27% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 26
Holders
134
Holding in Top 10
–
Calls
$2.02M
Puts
$2.08M
Top Buyers
| 1 | +$9.54M | |
| 2 | +$7.47M | |
| 3 | +$4.62M | |
| 4 |
Morgan Stanley
New York
|
+$3.7M |
| 5 |
BlackRock
New York
|
+$2.28M |
Top Sellers
| 1 | -$17.4M | |
| 2 | -$11M | |
| 3 | -$8.01M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$6.12M |
| 5 |
Renaissance Technologies
New York
|
-$2.88M |